La vendita allo scoperto per Innovative Ind Props dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Innovative Ind Props. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Innovative Ind Props (NYSE:IIPR) Azioni, Report sulle vendite allo scoperto

Innovative Ind Props

Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.

Innovative Industrial Properties, Inc. Common Stock

Innovative Industrial Properties Inc

Innovative Industrial Properties, Inc. 9.00% Series A Cumulative Redeemable Preferred Stock

News

Trading Ideas

CPNG

FLUT

Tiger Global 13F Shows Added Stake In Flutter Entertainment With 3,377,392 Shares; Added Stake In Sherwin-Williams Co With 527,805 Shares; Added Stake In Coupang With 1,994,058 Shares

WIIM

CRNX

Crinetics Pharmaceuticals shares are trading higher after Citigroup maintained a Buy rating on the stock and raised its price target from $70 to $74.

President-elect Donald Trump's proposal to establish a national Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reserve has sparked a wave of support across the United States, with Pennsylvania leading the charge by considering its own <a href="https://www.benzinga.com/24/11/41890600/anthony-scaramucci-optimistic-of-a-us-strategic-bitcoin-reserve-trumps-victory-accelerated-the-cycle">state-held cryptocurrency reserve</a>.
What Happened: This movement aligns with Trump&#8217;s promise to make the U.S. the "<a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40734266/trump-promised-to-turn-the-u-s-into-the-crypto-capital-of-the-world-but-did-he-actually-fo">crypto capital of the planet</a>" and has fueled legislative efforts to recognize Bitcoin as a secure state asset, FOX Business <a href="https://www.foxbusiness.com/money/pennsylvania-house-introduces-bill-implement-strategic-bitcoin-reserve">reports</a>.
In Pennsylvania, lawmakers introduced the Pennsylvania Bitcoin Strategic Reserve Act, the first bill of its kind, which would authorize the state's treasury to invest up to 10% of its $7 billion reserves into Bitcoin to hedge against inflation and diversify from traditional assets like bonds and cash.
The bill is set to be a historic move toward recognizing digital assets in state portfolios.
&#8220;The Pennsylvania Bitcoin Strategic Reserve Act is a forward-thinking move to protect our financial future," said Republican state Rep. Mike Cabell, who sponsors the bill. "By integrating Bitcoin, we're safeguarding Pennsylvania against inflation's unrelenting impact while positioning ourselves as pioneers in financial resilience and innovation."
The push for <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41938972/donald-trump-to-establish-a-national-bitcoin-reserve-a-30-chance-polymarket-traders-speculate">state-held Bitcoin reserves</a> follows a recent upswing in Bitcoin's value, with prices jumping 20% in the week following Trump's election victory.
Bitcoin recently reached an all-time high of over $93,000 per token, making it the seventh-largest global asset, trailing only behind gold and tech giants like Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Google (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>).
This state legislation echoes growing momentum for pro-Bitcoin policies at the federal level.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41976407/ben-horowitz-the-biden-regulators-lied-about-crypto">Ben Horowitz: &#8216;The Biden Regulators Lied About Crypto&#8217;</a>
U.S. Senator Cynthia Lummis of Wyoming, a well-known cryptocurrency advocate, plans to introduce a <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41784950/pro-bitcoin-senator-cynthia-lummis-vows-to-build-a-strategic-bitcoin-reserve-as-industry-e">national Bitcoin reserve bill</a> within the first 100 days of Trump's presidency.
Pennsylvania has also advanced the Bitcoin Rights bill, a proposal aimed at protecting residents' rights to self-custody and use Bitcoin for payments. 
The bipartisan support for this bill, which passed the Democrat-led House by a vote of 176-26, sets a positive precedent for the Pennsylvania Bitcoin Strategic Reserve Act.
Dennis Porter, founder of the Satoshi Action Fund (SAF), an advocacy group that helped develop both bills, sees Pennsylvania's efforts as a model for other states. 
Porter noted that SAF is already in discussions with ten other states about enacting similar legislation, saying, "With public interest in Bitcoin at an all-time high, we anticipate both bills will pass and, ideally, be signed into law next year."
If successful, Pennsylvania would become the first state to incorporate Bitcoin directly into its balance sheet, potentially setting a trend for other states to integrate digital assets into economic strategy. 
"This legislation sends a powerful message," Cabell emphasized. "Pennsylvania is ready to adopt modern financial solutions to secure prosperity for future generations."
The evolution of Pennsylvania's pro-Bitcoin stance highlights a significant trend in the adoption of cryptocurrency at the state level and may pave the way for digital assets to play an increasingly prominent role in U.S. economic policy.
As the policy debate intensifies, the cryptocurrency community, government officials, and investors will gather at Benzinga&#8217;s <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19, to explore how these legislative shifts could shape the future of digital finance in America.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41973094/elon-musk-says-excess-government-spending-causes-inflation-as-donald-trump-fills-administration-with-cryptocurrency-advocates">Elon Musk Says Excess Government Spending &#8216;Causes Inflation&#8217; As Donald Trump Fills Administration With Cryptocurrency Advocates</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

AAPL

AMZN

GOOGL

Pennsylvania Introduces Bitcoin Strategic Reserve Act To Invest Up To $700 Million In BTC

On Thursday, GSK plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) released headline results from a planned interim analysis of the DREAMM-7 head-to-head phase 3 trial of Blenrep (belantamab mafodotin) in combination with bortezomib plus dexamethasone (BorDex) as a second-line or later treatment for relapsed or <a target="_blank" href="https://www.benzinga.com/general/biotech/23/11/35954764/gsk-frames-a-comeback-for-its-multiple-myeloma-drug-following-encouraging-phase-3-data" rel="noreferrer noopener">refractory multiple myeloma</a>.
The trial <a target="_blank" href="https://www.gsk.com/en-gb/media/press-releases/blenrep-shows-overall-survival-benefit-in-head-to-head-dreamm-7-phase-iii-trial-for-relapsedrefractory-multiple-myeloma/" rel="noreferrer noopener">met</a> the key secondary endpoint of overall survival (OS), showing that belantamab mafodotin when combined with BorDex significantly reduced the risk of death versus standard of care daratumumab plus BorDex.
The interim analysis results, including safety data, will be presented at the upcoming American Society of Hematology Annual Meeting and Exposition.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41624198/gsks-q3-earnings-hit-by-lower-than-expected-vaccine-sales-cautions-lower-revenue-for-2024" rel="noreferrer noopener">GSK&#8217;s Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024</a>
A phase 3 study in newly diagnosed transplant-ineligible multiple myeloma is expected to be initiated by the end of 2024 as part of the DREAMM program.
In 2024, belantamab mafodotin combinations have been filed in the U.S.,&nbsp;European Union,&nbsp;Japan, United Kingdom, Canada, and Switzerland for relapsed or refractory multiple myeloma based on the results of the DREAMM-7 and DREAMM-8 trials.
In 2022, GSK withdrew the U.S. marketing authorization for Blenrep following the FDA request, based on the previously announced outcome of the DREAMM-3 Phase 3 confirmatory trial,&nbsp;which did not meet the requirements of the FDA <a target="_blank" href="https://www.benzinga.com/general/biotech/22/11/29818040/after-disappointing-confirmatory-study-gsk-to-withdraw-approved-blood-cancer-drug-in-us" rel="noreferrer noopener">Accelerated Approval regulations</a>.&nbsp;
In June, GSK released&nbsp;results from an interim analysis of the DREAMM-8 phase 3 head-to-head trial of Blenrep in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care, bortezomib plus PomDex for relapsed or&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/06/39144773/gsks-blenrep-combo-therapy-cuts-risk-of-disease-progression-or-death-by-around-50-in-pretreated-m" rel="noreferrer noopener">refractory multiple myeloma</a>.
On the primary endpoint of progression-free survival (PFS), the belantamab mafodotin combination (n=155) showed a statistically significant and clinically meaningful improvement compared to the bortezomib combination (n=147).
Price Action: GSK stock is down 0.01% at $35.11 at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41977487/ac-immunes-active-immunotherapy-shows-antibody-responses-in-early-parkinsons-patients" target="_blank" rel="noreferrer noopener">AC Immune&#8217;s Active Immunotherapy Shows Antibody Responses In Early Parkinson&#8217;s Patients</a></li>
</ul>

Biotech

Large Cap

Eurozone

Health Care

General

GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why

Analysts revised the price target or estimates on Plug Power, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) after the company reported weak<a target="_blank" href="https://www.benzinga.com//node/41941424" rel="noreferrer noopener"> third-quarter results and provided FY25 guidance.</a>
On Wednesday, Plug provided its financial outlook for 2025, projecting revenue between $850 million and $950 million (street view: $1.185 billion).&nbsp;
Looking further ahead, the company aims for a target revenue of <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">approximately $3.75 billion by 2030</a>.
Also this week, Plug Power reported third-quarter revenue of $173.73 million, which missed the consensus of $210.23 million and EPS loss of 25 cents, missed<a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41912702/plug-power-stock-slides-on-q3-earnings-revenue-miss-eps-miss-soft-guidance-and-more" rel="noreferrer noopener"> estimate for a loss of 24 cents</a>.
The company expects its full-year 2024 revenue outlook&nbsp;of $700 million and $800 million&nbsp;versus estimates of $823.46 million.
Piper Sandler analyst Kashy Harrison cut the price target to $1.40 from $1.60 while maintaining an Underweight rating.
The analyst writes that Plug&#8217;s results missed expectations but weren&#8217;t as weak as anticipated. While cash burn improved year-over-year, it remains high, requiring continued capital raises despite potential DOE loan support for Texas CapEx (annualized OCF: -$700 million).
The rationale for U.S. grid-tied green hydrogen projects is unclear due to power shortages, though European development may benefit from government support, adds the analyst.
Thus, the analyst estimates fourth-quarter revenues at $193 million, below the Street&#8217;s $280 million estimate.
JP Morgan analyst Bill Peterson maintained a Neutral rating on the stock.
The analyst writes that he found the more cautiously optimistic tone refreshing, with an acknowledgment that the broader hydrogen industry is likely to see gradual growth in the near- to mid-term.
Plug&#8217;s goals to achieve EBITDA-positive in second half of FY26 and profitability by 2028 still suggest the need for additional capital raises—estimated at $1 billion—despite the DOE loan, given the company&#8217;s fragile cash position, adds the analyst.
The analyst says that if the company executes well in 2025, it could pave the way for a stronger 2026 and growth in the latter part of the decade, contingent on factors like the DOE loan closure and final 45V guidance.
Morgan Stanley analyst Andrew S Percoco reaffirmed an Underweight rating with a price target of $1.75.
The analyst maintains a cautious outlook on green hydrogen, which presents ongoing risks to the company&#8217;s long-term growth and margins.
Percoco estimates that PLUG will need to issue an additional $500 million in equity through the first half of FY25 to cover its near-term cash burn, with DOE funding expected to start in the second quarter of 2025.
Roth analyst Craig Irwin reiterated the Buy rating and a price target of $5.00, with a 2025 revenue estimate of $900 million. This reflects the successful generation of Green Hydrogen PTC in Georgia and the improving visibility of gross margin gains in second half of FY25.
PLUG&#8217;s shares may experience increased volatility due to the high valuation on 2025 estimates, with company-specific and industry catalysts potentially causing significant shifts in long-term hydrogen economy projections, adds the analyst.
With a Perform rating, Oppenheimer analysts write that they view Plug&#8217;s commentary on green ammonia pricing as positive for electrolyzer demand and see the cryogenic business benefiting from LNG growth.
The analyst says that they are encouraged by PLUG&#8217;s focus on operational efficiencies, given its cash position, and notes investors are seeking greater consistency in its financial performance.
Truist Securities analyst Jordan Levy maintained a Hold rating with a price target of $2. The analyst writes that the updated targets suggest a more grounded reset of expectations.
It appears PLUG is shifting from a pattern of overpromising and underdelivering, acknowledging the slower-than-anticipated hydrogen market growth and tighter capital environment, adds the analyst.
Investors can gain exposure to the stock via&nbsp;Global X Hydrogen ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYDR#NASDAQ">HYDR</a>).
Price Action: PLUG shares are down 3.30% at $1.905 at the last check Thursday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/11/41926301/sustainable-investment-under-trump-performance-matters-far-more-than-politics-jpmorgan-analyst-says" target="_blank" rel="noreferrer noopener">Sustainable Investment Under Trump: &#8216;Performance Matters Far More Than Politics,&#8217; JPMorgan Analyst Says</a></li>
</ul>

Analyst Color

Equities

Mid Cap

Price Target

Reiteration

Analyst Ratings

HYDR

PLUG

What Is Plug Power's Future? Analysts Warn Of Cash Crunch And Slow Hydrogen Market Growth

Motorola Solutions, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>) today announced that its board of directors has increased its regular quarterly dividend by 11 percent to $1.09 per share. The next quarterly dividend will be payable in cash on January 15, 2025, to stockholders of record at the close of business on December 13, 2024.

Dividends

Motorola Solutions Increases Quarterly Dividend From $0.98 To $1.09 Per Share

SOUN

SoundHound AI shares are trading higher after HC Wainwright & Co. maintained a Buy rating on the stock and raised its price target from $7 to $8.

Earnings

ELAB

Elevai Labs Q3 EPS $(0.068) Up From $(0.078) YoY, Sales $527.48K Down From $554.65K YoY

Financial giants have made a conspicuous bearish move on Lockheed Martin. Our analysis of options history for Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) revealed 17 unusual trades.
Delving into the details, we found 23% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we spotted, 13 were puts, with a value of $701,289, and 4 were calls, valued at $318,390.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $485.0 to $590.0 for Lockheed Martin during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Lockheed Martin stands at 201.56, with a total volume reaching 1,815.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Lockheed Martin, situated within the strike price corridor from $485.0 to $590.0, throughout the last 30 days.
<h3>Lockheed Martin Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731613546_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LMT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$16.7</td>
<td>$16.6</td>
<td>$16.7</td>
<td>$535.00</td>
<td>$128.6K</td>
<td align="right">98</td>
<td align="right">87</td>
</tr>
<tr>
<td>LMT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$47.5</td>
<td>$46.0</td>
<td>$46.0</td>
<td>$570.00</td>
<td>$115.0K</td>
<td align="right">274</td>
<td align="right">25</td>
</tr>
<tr>
<td>LMT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$1.6</td>
<td>$1.4</td>
<td>$1.45</td>
<td>$485.00</td>
<td>$87.0K</td>
<td align="right">27</td>
<td align="right">600</td>
</tr>
<tr>
<td>LMT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$3.9</td>
<td>$3.6</td>
<td>$3.8</td>
<td>$570.00</td>
<td>$83.9K</td>
<td align="right">137</td>
<td align="right">230</td>
</tr>
<tr>
<td>LMT</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$20.4</td>
<td>$19.7</td>
<td>$20.1</td>
<td>$540.00</td>
<td>$70.3K</td>
<td align="right">339</td>
<td align="right">48</td>
</tr>
</tbody>
</table>

<h3>About Lockheed Martin</h3>
Lockheed Martin is the world's largest defense contractor and has dominated the Western market for high-end fighter aircraft since it won the F-35 Joint Strike Fighter program in 2001. Lockheed's largest segment is aeronautics, which derives upward of two-thirds of its revenue from the F-35. Lockheed's remaining segments are rotary and mission systems, mainly encompassing the Sikorsky helicopter business; missiles and fire control, which creates missiles and missile defense systems; and space systems, which produces satellites and receives equity income from the United Launch Alliance joint venture.
Having examined the options trading patterns of Lockheed Martin, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Lockheed Martin</h3>
<ul>
<li>Trading volume stands at 1,228,085, with LMT's price down by -3.37%, positioned at $538.92.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 68 days.</li>
</ul>
<h3>Professional Analyst Ratings for Lockheed Martin</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $655.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from TD Cowen persists with their Buy rating on Lockheed Martin, maintaining a target price of $610. 
&#x2A; Consistent in their evaluation, an analyst from Susquehanna keeps a Positive rating on Lockheed Martin with a target price of $695. 
&#x2A; An analyst from UBS has decided to maintain their Neutral rating on Lockheed Martin, which currently sits at a price target of $603. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Lockheed Martin with a target price of $665. 
&#x2A; An analyst from Susquehanna has decided to maintain their Positive rating on Lockheed Martin, which currently sits at a price target of $705. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Lockheed Martin, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

Looking At Lockheed Martin's Recent Unusual Options Activity

Financial giants have made a conspicuous bullish move on CrowdStrike Holdings. Our analysis of options history for CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) revealed 26 unusual trades.
Delving into the details, we found 46% of traders were bullish, while 34% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $239,635, and 20 were calls, valued at $1,311,593.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $200.0 to $480.0 for CrowdStrike Holdings over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for CrowdStrike Holdings's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across CrowdStrike Holdings's significant trades, within a strike price range of $200.0 to $480.0, over the past month.
<h3>CrowdStrike Holdings Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731613541_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$124.6</td>
<td>$122.6</td>
<td>$124.6</td>
<td>$260.00</td>
<td>$311.3K</td>
<td>392</td>
<td align="right">29</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$112.35</td>
<td>$111.95</td>
<td>$112.35</td>
<td>$280.00</td>
<td>$224.7K</td>
<td>323</td>
<td align="right">22</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$58.5</td>
<td>$58.0</td>
<td>$58.0</td>
<td>$300.00</td>
<td>$116.0K</td>
<td>2.5K</td>
<td align="right">28</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$2.45</td>
<td>$2.21</td>
<td>$2.35</td>
<td>$350.00</td>
<td>$58.7K</td>
<td>2.2K</td>
<td align="right">911</td>
</tr>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.3</td>
<td>$5.15</td>
<td>$5.3</td>
<td>$220.00</td>
<td>$58.3K</td>
<td>1.0K</td>
<td align="right">164</td>
</tr>
</tbody>
</table>

<h3>About CrowdStrike Holdings</h3>
CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.
After a thorough review of the options trading surrounding CrowdStrike Holdings, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is CrowdStrike Holdings Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,510,174, with CRWD's price down by -0.05%, positioned at $347.7.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 12 days.</li>
</ul>
<h3>Professional Analyst Ratings for CrowdStrike Holdings</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $400.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from JMP Securities downgraded its rating to Market Outperform, setting a price target of $400. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for CrowdStrike Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

CRWD

Decoding CrowdStrike Holdings's Options Activity: What's the Big Picture?

Deep-pocketed investors have adopted a bearish approach towards Mobileye Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MBLY usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Mobileye Global. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 22% leaning bullish and 33% bearish. Among these notable options, 5 are puts, totaling $421,273, and 4 are calls, amounting to $694,236.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $12.0 to $21.0 for Mobileye Global over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Mobileye Global's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Mobileye Global's whale trades within a strike price range from $12.0 to $21.0 in the last 30 days. 
<h3>Mobileye Global Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731613536_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MBLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$2.6</td>
<td>$2.35</td>
<td>$2.37</td>
<td>$14.00</td>
<td>$592.5K</td>
<td>1.1K</td>
<td>2.5K</td>
</tr>
<tr>
<td>MBLY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$5.5</td>
<td>$5.3</td>
<td>$5.4</td>
<td>$15.00</td>
<td>$99.5K</td>
<td>152</td>
<td>225</td>
</tr>
<tr>
<td>MBLY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.4</td>
<td>$5.2</td>
<td>$5.2</td>
<td>$21.00</td>
<td>$94.6K</td>
<td>831</td>
<td>185</td>
</tr>
<tr>
<td>MBLY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$5.5</td>
<td>$5.3</td>
<td>$5.4</td>
<td>$15.00</td>
<td>$94.2K</td>
<td>152</td>
<td>408</td>
</tr>
<tr>
<td>MBLY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$3.8</td>
<td>$3.6</td>
<td>$3.7</td>
<td>$12.00</td>
<td>$68.2K</td>
<td>1.9K</td>
<td>225</td>
</tr>
</tbody>
</table>

<h3>About Mobileye Global</h3>
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. Mobileye is the Company's only reportable operating segment. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System &amp; Vehicles. It also provides data services to Expedite Maintenance Operations with AI-Powered Road Survey Technology.
After a thorough review of the options trading surrounding Mobileye Global, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Mobileye Global Standing Right Now?</h3>
<ul>
<li>With a trading volume of 5,576,962, the price of MBLY is down by -7.89%, reaching $15.95.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 70 days from now.</li>
</ul>
<h3>Expert Opinions on Mobileye Global</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $20.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from TD Cowen keeps a Buy rating on Mobileye Global with a target price of $19. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Mobileye Global, which currently sits at a price target of $18. 
&#x2A; Reflecting concerns, an analyst from Loop Capital lowers its rating to Buy with a new price target of $20. 
&#x2A; Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Buy rating on Mobileye Global with a target price of $25. 
&#x2A; An analyst from Needham persists with their Buy rating on Mobileye Global, maintaining a target price of $20. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Mobileye Global options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

MBLY

Mobileye Global Options Trading: A Deep Dive into Market Sentiment

<a href="https://www.bloomberg.com/news/articles/2024-11-14/amazon-questioned-by-congress-over-growing-tiktok-relationship">https://www.bloomberg.com/news/articles/2024-11-14/amazon-questioned-by-congress-over-growing-tiktok-relationship</a>
&nbsp;
Representatives from <a href="https://www.bloomberg.com/quote/AMZN:Us">Amazon.com Inc.</a> were called to Capitol Hill for a closed-door meeting with a key House committee earlier this fall to answer questions about the retail giant's deepening relationship with the Chinese-owned video-sharing app TikTok.
The House Select Committee on China summoned Amazon in September to discuss with staffers a <a href="https://ads.tiktok.com/business/en-US/blog/amazon-ads-native-checkout?ab_version=control">high-profile shopping partnership</a> the two companies announced in August, according to multiple people familiar with the matter. The meeting has not been previously reported.

'Amazon Questioned By Congress Over Growing TikTok Relationship' - Bloomberg News

BofA Securities analyst Jessica Reif Ehrlich reiterated a Buy rating on Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a price target of $120.
Ehrlich maintained a positive outlook on Disney following its mixed fiscal fourth-quarter results, focusing on its guidance for fiscal 2025 and beyond.
Disney&#8217;s fiscal fourth-quarter revenue grew 6.3% year-over-year to $22.6 billion, slightly above Ehrlich&#8217;s forecast of $22.3 billion. Operating income (OI) increased by 16% to $3.66 billion but fell below her estimated $3.70 billion. Adjusted EPS came in at $1.14, surpassing the <a href="https://www.benzinga.com/24/11/41971559/disneys-q4-boosted-by-streaming-gains-strong-box-office-and-solid-parks-performance">analyst&#8217;s forecast of $1.11.</a>
By segment, Entertainment OI reached $1.07 billion ($1.06 billion expectations), while Sports OI came in lower at $929 million versus the estimated $966 million. Experiences OI matched the forecast at $1.7 billion.
Disney provided its initial guidance for fiscal 2025, targeting high single-digit growth in adjusted EPS, estimated between $5.26 and $5.41, up from the fiscal 2024 base of $4.97. Ehrlich expects double-digit OI growth in the Entertainment segment, 13% OI growth in Sports, and 6-8% growth in Experiences.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/24/11/41915397/netflix-reaches-70-million-users-on-ad-supported-plan-boosts-live-sports-ads" rel="noreferrer noopener">Netflix Reaches 70 Million Users On Ad-Supported Plan, Boosts Live Sports Ads</a>
The company aims for $15 billion in operating cash flow, with $8 billion allocated for capital expenditures, implying about $7 billion in free cash flow. Additionally, Disney plans to increase dividends in line with earnings growth and conduct $3 billion in share repurchases. For fiscal 2026 and 2027, Ehrlich forecasts double-digit EPS growth, driven by improved margins in the streaming segment and overall earnings expansion.
In the Entertainment division, Linear Networks OI was lower at $498 million, impacted by a decline in domestic revenue due to non-renewed carriage agreements and reduced advertising income. Conversely, Direct-to-Consumer (DTC) OI exceeded estimates, reaching $253 million, boosted by a net increase of 4.4 million Disney+ subscribers and higher subscription revenue from recent price hikes. 
Content Sales and Licensing outperformed expectations with $316 million in OI, fueled by strong quarterly theatrical releases. Experiences revenue reached $8.24 billion, driven by 3% domestic growth, although international revenue declined by 5%. Ehrlich noted increased costs from inflation and technology investments, which slightly compressed margins.
The Sports segment reported flat year-over-year revenue of $3.91 billion, slightly below the $3.98 billion estimate. Operating income declined by 5.3% to $929 million due to lower affiliate revenue linked to decreased subscribers. Higher advertising revenue and increased programming costs partially offset this decline.
Ehrlich valued the stock at 22 times her calendar 2025 adjusted EPS estimate. The premium reflects Disney&#8217;s strong asset portfolio, including leading content and top-tier theme parks. Ehrlich pointed to two critical near-term catalysts: profitability improvements in the DTC segment and a recovery in the parks business, justifying the multiple valuations in line with Disney&#8217;s historical premium.
Walt Disney stock gained 21% year-to-date. Investors can gain exposure to the stock through The Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) and SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>).
Price Actions: DIS stock is up 6.45% at $109.34 at the last check on Thursday.
Image via Shutterstock
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41934651/tencent-q3-earnings-gaming-and-ai-fuel-profit-growth-pony-ma-eyes-e-commerce-expansion" target="_blank" rel="noreferrer noopener">Tencent Q3 Earnings: Gaming And AI Fuel Profit Growth, Pony Ma Eyes E-Commerce Expansion</a></li>
</ul>

SPDR Dow Jones Industrial Average ETF Trust

Disney's Streaming Profits And Park Rebound Lead The Way: Analyst

LDOS

SAIC

Shares of companies that do business as government contractors are trading lower as President-elect Trump makes federal appointments during his transition period. Investors may evaluate the impact of possible cuts from the "Department of Government Efficiency".

Cybersecurity company Palo Alto Networks (PANW) reports next week and with a wide range of stock moves possible for after, let's consider setting up a double butterfly formation.
This kind of trade will allow us to profit from the stock moving in either direction.
Let me show you.
<h2 class="wp-block-heading">Trade structure – the long double butterfly setup</h2>
A double butterfly is ideal for larger anticipated moves into a catalyst like earnings. This setup is a combination of a long call butterfly and a long put butterfly.
A long call butterfly is the combination of a long call spread and a short call spread that share the same short strike. A long put butterfly is the combination of a long put spread and a short put spread that share the same short strike. They are positioned as two separate trades.
The long call butterfly (positioned for upside):
<ul>
<li>Buy to open 1 PANW 20 Dec 450 calls</li>
<li>Sell to open 2 PANW 20 Dec 460 calls</li>
<li>Buy to open 1 PANW 20 Dec 470 calls</li>
</ul>
The long put butterfly (positioned for downside):
<ul>
<li>Buy to open 1 PANW 20 Dec 330 puts</li>
<li>Sell to open 2 PANW 20 Dec 320 puts</li>
<li>Buy to open 1 PANW 20 Dec 310 puts</li>
</ul>
The long call butterfly holds a current debit of $0.97 at this writing and the long put butterfly holds a current debit of $0.67. Together, the total risk is the debit you have paid for both butterflies, or if you have a definitive bias, you can engage in only one of them. &nbsp;
The total potential profit is $10 (the distance between strikes) and the cost of the debit ($0.97 + $0.67=$1.64) $10 &#8211; $1.64 = $8.36
It is extremely rare to collect all this premium. Instead, I like to consider 200%-300% profit of the investment.
<h2 class="wp-block-heading">Trade Management</h2>
The relative resistance zone sits right around $400 but traders are pricing in a wider range particularly after looking at the last three earnings moves have either continued in the move or changed direction sharply. The relative support is near $330.
The strategy result provides only two choices to exit the trade:
<ol>
<li>To sell the butterfly that is performing at your target parameters, particularly once the middle strike is tested.</li>
<li>To sell the both butterflies right after earnings if the chart does nothing, or once your threshold for loss is hit. Mine is typically 65-70% with these positions.</li>
</ol>
Our "Perfect Stock" Portfolio features a curated selection of expert-picked stocks with proven track records, designed for steady growth. Access investments built to outperform the market today. <a href="https://www.benzinga.com/premium/ideas/perfect-portfolio/?utm_source=RD-1114">Click to get access now.</a>
Image via Unsplash

Opinion

Profit 2 Ways From A Single Earnings Report With This Unique Trade

cbdMD, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#NYSE">YCBD</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#NYSE">YCBD</a>) a trusted leader in the wellness and cannabinoid industry, is excited to announce the launch of Herbal Oasis Social Tonics—a carefully crafted low-calorie, hemp derived THC seltzer line designed to elevate social occasions with a blend of premium cannabinoids and adaptogenic mushrooms. Available in four delicious flavors—Lemon Lift, Tropical Twist, Mango Bliss, and Berry Fusion—Herbal Oasis is designed to deliver an experience that enhances social connection and well-being, offering an alternative to traditional alcoholic drinks.
As the first entry of its kind for cbdMD, the Company believes Herbal Oasis is set to redefine what social drinking can look like in a wellness-centered lifestyle. Each can features a thoughtfully balanced formula: 5mg of hemp derived THC and 5mg of CBG, complemented by a nootropic blend of functional ingredients like Lion's Mane, Reishi, Maitake, and Cordyceps mushrooms along with L-theanine and B12. With a focus on enhancing social experiences, this blend is crafted to provide calm, clarity, and energy, helping consumers feel engaged, vibrant, and connected in any social setting.

YCBD

cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers, Designed To Elevate Social Occasions With A Blend Of Premium Cannabinoids And Adaptogenic Mushrooms

BCAB

Scion Asset Management 13F Shows Exited Position In Hudson Pacific Properties, Previously Holding 1,144,435 Shares; Exited Position In BioAtla, Previously Holding 633,959 Shares

Cronos group CEO Mike Gorenstein (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) says the cannabis industry should not rely solely on Democratic leadership for reform.
Instead, he says President-elect Donald Trump is personally more open to cannabis reform than Biden, but warned against expecting rapid changes, as cannabis won&#8217;t be a top priority for the new administration.
<h3 class="wp-block-heading">Trump vs. Biden: Cannabis Reform Expectations</h3>
In a recent appearance on Cultivated with Jay Rosenthal via X (formerly Twitter), Gorenstein shared his views on the political landscape following the November elections.
Despite <a href="https://www.benzinga.com/markets/cannabis/24/11/41855573/cannabis-stocks-plunged-after-florida-legalization-failed-rational-reaction-or-market-overreach">poor market response</a> to the results, Gorenstein remains optimistic. He pointed out the successes in red and purple states while acknowledging that traditional blue-state markets like California and Massachusetts are not the best examples of cannabis markets.
In the midst of the expectations created by Trump&#8217;s<a href="https://www.benzinga.com/news/legal/24/11/41956594/matt-gaetz-is-trumps-attorney-general-pick-would-be-top-cop-is-under-house-ethics-investigation"> </a><a href="https://www.benzinga.com/news/legal/24/11/41959036/trump-nominates-another-cannabis-supporter-to-cabinet-rep-matt-gaetz-for-attorney-general">nomination</a> of cannabis legalization supporter Matt Gaetz to his cabinet, Gorenstein advised caution about expecting significant changes in the near future, pointing out that while Trump might be more favorable, cannabis is unlikely to be a top priority for incoming administration.
"As far as timing, you can&#8217;t expect it to happen next year. There's a lot of things that need to be done, and it's not the primary issue," he added.
Read Also: <a href="https://www.benzinga.com/news/earnings/24/11/41904096/cronos-cannabis-co-reports-38-yoy-increase-in-q3-revenue-boosts-international-sales">Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General</a>
<h3 class="wp-block-heading">Focusing on Strategy, Not Stock Prices</h3>
Discussing Cronos&#8217; approach, Gorenstein said the company does not need to issue more shares. Instead they are focusing on building a strong portfolio of high-quality cannabis products and expanding to global markets such as <a href="https://www.benzinga.com/topic/germany-cannabis">Germany</a>.
The company is going through a good moment that reflects in the fact they are running low on product, and needing to invest on escalation of their current operations to catch up with the growing demand.
Still, prices cannabis stocks have been on a <a href="https://www.benzinga.com/markets/cannabis/24/11/41793174/cannabis-stocks-collapse-after-trump-win-major-players-see-double-digit-declines-at-wednesdays-c">downtrend</a>, but for Gorenstein, &#8220;you just get used to volatility&#8230; it's a real mistake and a trap to follow stocks every day."
<h3 class="wp-block-heading">Earnings Report Q3 2024</h3>
Recently Cronos Group <a href="https://www.benzinga.com/news/earnings/24/11/41904096/cronos-cannabis-co-reports-38-yoy-increase-in-q3-revenue-boosts-international-sales">reported</a> Q3 2024 net revenue of $34.3 million, a 38% increase driven by stronger cannabis sales across Canada, Israel, and international markets. 
Despite a net income turnaround to $7.3 million, adjusted EBITDA remained negative at $6 million.
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/06/39418098/cronos-cannabis-co-will-provide-51m-to-growco-toward-facility-expansion-fund">Cronos Cannabis Co. Will Provide $51M To GrowCo Toward Facility Expansion Fund</a></li>
</ul>
COVER: <a href="https://unsplash.com/@kiffen?utm_content=creditCopyText&amp;utm_medium=referral&amp;utm_source=unsplash" target="_blank" rel="noreferrer noopener">GRAS GRÜN</a>&nbsp;on&nbsp;<a href="https://unsplash.com/photos/ground-cannabis-on-clear-plastic-bag-iCHacuW8BcI?utm_content=creditCopyText&amp;utm_medium=referral&amp;utm_source=unsplash" target="_blank" rel="noreferrer noopener">Unsplash</a><a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Cannabis

Media

CRON

Cronos CEO Mike Gorenstein Says He's Optimistic About Trump's Impact On Cannabis

Whales with a lot of money to spend have taken a noticeably bearish stance on Citigroup.
Looking at options history for Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) we detected 22 trades.
If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with bullish expectations and 59% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $211,613 and 17, calls, for a total amount of $732,862.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $50.0 to $90.0 for Citigroup over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Citigroup stands at 14385.71, with a total volume reaching 32,890.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Citigroup, situated within the strike price corridor from $50.0 to $90.0, throughout the last 30 days.
<h3>Citigroup Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731612791_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$1.29</td>
<td>$1.26</td>
<td>$1.26</td>
<td>$70.00</td>
<td>$74.5K</td>
<td>14.5K</td>
<td>1.6K</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$5.0</td>
<td>$4.95</td>
<td>$5.0</td>
<td>$65.00</td>
<td>$62.0K</td>
<td>16.3K</td>
<td>159</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$20.6</td>
<td>$20.2</td>
<td>$20.2</td>
<td>$50.00</td>
<td>$60.6K</td>
<td>4.3K</td>
<td>30</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.78</td>
<td>$2.74</td>
<td>$2.74</td>
<td>$70.00</td>
<td>$58.9K</td>
<td>73.6K</td>
<td>231</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.53</td>
<td>$1.52</td>
<td>$1.52</td>
<td>$72.50</td>
<td>$55.6K</td>
<td>28.1K</td>
<td>2.3K</td>
</tr>
</tbody>
</table>

<h3>About Citigroup</h3>
Citigroup is a global financial-services company doing business in more than 100 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.
Having examined the options trading patterns of Citigroup, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Citigroup's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 9,127,274, the C's price is down by -1.34%, now at $67.97. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 62 days.</li>
</ul>
<h3>Expert Opinions on Citigroup</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $82.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Citigroup, targeting a price of $107. 
&#x2A; An analyst from Evercore ISI Group has decided to maintain their In-Line rating on Citigroup, which currently sits at a price target of $64. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Citigroup, which currently sits at a price target of $82. 
&#x2A; An analyst from Oppenheimer has decided to maintain their Outperform rating on Citigroup, which currently sits at a price target of $91. 
&#x2A; An analyst from Barclays persists with their Equal-Weight rating on Citigroup, maintaining a target price of $70. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Citigroup options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Citigroup's Options Frenzy: What You Need to Know

Investors with a lot of money to spend have taken a bearish stance on Iris Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with IREN, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 25 uncommon options trades for Iris Energy.
This isn't normal.
The overall sentiment of these big-money traders is split between 24% bullish and 76%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $363,576, and 18 are calls, for a total amount of $1,432,624.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $7.5 and $25.0 for Iris Energy, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Iris Energy stands at 9568.85, with a total volume reaching 24,574.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Iris Energy, situated within the strike price corridor from $7.5 to $25.0, throughout the last 30 days.
<h3>Iris Energy Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731612786_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.9</td>
<td>$3.7</td>
<td>$3.72</td>
<td>$8.00</td>
<td>$354.1K</td>
<td>4.3K</td>
<td>1.0K</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$3.8</td>
<td>$3.2</td>
<td>$3.3</td>
<td>$10.00</td>
<td>$164.3K</td>
<td>6.1K</td>
<td>686</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$2.95</td>
<td>$2.9</td>
<td>$2.9</td>
<td>$12.00</td>
<td>$162.1K</td>
<td>7.4K</td>
<td>1.8K</td>
</tr>
<tr>
<td>IREN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$1.7</td>
<td>$1.6</td>
<td>$1.62</td>
<td>$11.50</td>
<td>$121.5K</td>
<td>261</td>
<td>750</td>
</tr>
<tr>
<td>IREN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.4</td>
<td>$3.3</td>
<td>$3.4</td>
<td>$12.50</td>
<td>$90.1K</td>
<td>38.9K</td>
<td>913</td>
</tr>
</tbody>
</table>

<h3>About Iris Energy</h3>
Iris Energy Ltd is a Bitcoin mining company. It builds, owns, and operates data centers and electrical infrastructure for the mining of Bitcoin powered by renewable energy. The company's mining operations generate revenue by earning Bitcoin through a combination of block rewards and transaction fees from the operation of its specialized computers called Application-specific Integrated Circuits and exchanging these Bitcoin for currencies such as USD or CAD on a daily basis.
Following our analysis of the options activities associated with Iris Energy, we pivot to a closer look at the company's own performance.
<h3>Where Is Iris Energy Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 13,425,692, with IREN's price down by -4.09%, positioned at $10.44.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 12 days.</li>
</ul>
<h3>Professional Analyst Ratings for Iris Energy</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $20.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $20.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Iris Energy options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

IREN

Iris Energy's Options: A Look at What the Big Money is Thinking

Reports Q3 revenue $76.53M, consensus $77.38M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news...

Innovative Industrial reports Q3 AFFO $2.25, consensus $2.29

Innovative Industrial Properties Q3 earnings miss consensus amid rent delays from repo properties

Innovative Industrial Properties, Inc. (IIPR) Q3 2024 Earnings Call Transcript

Innovative Industrial Properties ( ($IIPR) ) has provided an announcement. Innovative Industrial Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) is a unique real est...

Innovative Industrial Properties Strengthens Cannabis Real Estate Portfolio

Compass Point analyst Merrill Ross upgraded Innovative Industrial Properties (IIPR) to Buy from Neutral with an unchanged price target of $125. Pub...

Innovative Industrial Properties upgraded to Buy from Neutral at Compass Point

As previously reported, Compass Point analyst Merrill Ross upgraded Innovative Industrial Properties (IIPR) to Buy from Neutral with an unchanged p...

Compass Point upgrades Innovative Industrial, sees opportunity after selloff

Piper Sandler lowered the firm's price target on Innovative Industrial Properties (IIPR) to $118 from $120 and keeps a Neutral rating on the shares...

Innovative Industrial Properties price target lowered to $118 from $120 at Piper Sandler

My Portfolio's Biggest Winners And Losers From A Republican Sweep

Real estate stocks advance on rate cut, election results not-so-positive

Innovative Industrial Properties Falls After Florida Vote And Earnings Miss, But It Now Yields Over 7%

BBRE

BEPC

CTRE

CWEN

DFAR

FREL

HASI

IIPR

INDS

JPRE

KBWY

MORT

NETL

NURE

PPTY

REIT

ROOF

RSPR

SCHD

SCHH

SGOV

SILA

SPRE

SRVR

STWD

USRT

XLRE

Press Releases

Innovative Industrial Properties Acquires Florida Property and Expands Long-Term Real Estate Partnership with AYR Wellness

Innovative Industrial Properties Declares Second Quarter 2024 Dividends

Innovative Industrial Properties to Report 2024 Second Quarter Results

Innovative Industrial Properties Reports Second Quarter 2024 Results

Innovative Industrial Properties Declares Third Quarter 2024 Dividends

Innovative Industrial Properties to Report 2024 Third Quarter Results

Innovative Industrial Properties Reports Third Quarter 2024 Results

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Innovative Industrial Properties, Inc. - IIPR

IIPR Investors Have Opportunity to Join Innovative Industrial Properties, Inc. Fraud Investigation with the Schall Law Firm

Comments

Innovative Ind Props

Vendite allo scoperto

Innovative Ind Props (NYSE:IIPR) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO